Novel reaction to new cystic fibrosis medication Trikafta-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel reaction to new cystic fibrosis medication Trikafta

Published:2021-05 Issue:5 Volume:9 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Stashower Julian¹^ORCID,Carr Patrick²,Miller Virginia³,Zlotoff Barrett⁴

Affiliation:

1. University of Virginia School of Medicine Charlottesville VA USA

2. Department of Dermatology University of Virginia School of Medicine Charlottesville VA USA

3. Department of Pathology University of Virginia School of Medicine Charlottesville VA USA

4. Departments of Dermatology and Pediatrics Pediatric Dermatology University of Virginia School of Medicine Charlottesville VA USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.4116

Reference5 articles.

1. “Urticaria Multiforme”: A Case Series and Review of Acute Annular Urticarial Hypersensitivity Syndromes in Children

2. Urticaria multiforme;Emer JJ;J Clin Aesthet Dermatol,2013

3. Elexacaftor/Ivacaftor/Tezacaftor: First Approval

4. VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles

5. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous manifestations of cystic fibrosis;Journal of the American Academy of Dermatology;2024-09

2. Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis;Pharmaceuticals;2023-03-08

3. Drug-induced acne with elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis;Journal of Cystic Fibrosis;2022-11

4. Newly Discovered Cutting-Edge Triple Combination Cystic Fibrosis Therapy: A Systematic Review;Cureus;2022-09-20

5. Malassezia Folliculitis following Triple Therapy for Cystic Fibrosis;Medicina;2022-09-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3